NCT05904262

Brief Summary

The aim of our study was to investigate the effect of sole sensation on peripheral muscle strength, functional capacity, balance and physical activity level in individuals with Type 2 Diabetes Mellitus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

June 6, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 15, 2023

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2023

Completed
Last Updated

July 27, 2023

Status Verified

July 1, 2023

Enrollment Period

19 days

First QC Date

May 24, 2023

Last Update Submit

July 25, 2023

Conditions

Keywords

Diabetic FootDiabetic NeuropathiesType 2 Diabetes Mellitus

Outcome Measures

Primary Outcomes (1)

  • Foot Sole Sensation Evaluation

    Light touch pressure sensation will be assessed with the 10-g monofilament -Semmes Weinstein test. A 128 Hz diapause will be used to test the sense of vibration. Firstly, the diaposon will be applied to the patient's wrist (it can be on the elbow or clavicle), so that the patient will know what to experience beforehand. The diapozone is placed on the bone on the dorsal side of the distal phalanx of the first toe of the foot.For two-point discrimination sensation, two-point discrimination distance measurement with an esthesiometer (Baseline® , White Plains, NY, USA) will be used

    20 minute

Secondary Outcomes (7)

  • Body mass index

    5 minute

  • Body Fat

    5 minute

  • Skeletal muscle mass

    5 minute

  • Resting metabolism

    5 minute

  • Balance

    20 minute

  • +2 more secondary outcomes

Study Arms (1)

Type 2 diabetic patients

Type 2 Diabetes Mellitus. In this prospective study based on face-to-face interview method; body fat (%), skeletal muscle mass (%) (with Omron BF511 Body Composition Monitor), waist and hip circumference, lower extremity muscle strength (for quadriceps and biceps muscles) (with muscle hand held dynamometer), It is planned to measure upper extremity muscle strength (grip strength) (with hand grip dynamometer), functional capacity (with 6 Minute Walk Test), postural stability, stability limits and sensory integration of balance (with Biodex Balance System®). In addition, individuals are expected to answer the questions of the International Physical Activity Questionnaire-Short Form (IPAQ) to evaluate their physical activity levels.

Other: Foot Sole Sensation Evaluation

Interventions

Type 2 Diabetes Mellitus. In this prospective study based on face-to-face interview method; body fat (%), skeletal muscle mass (%) (with Omron BF511 Body Composition Monitor), waist and hip circumference, lower extremity muscle strength (for quadriceps and biceps muscles) (with muscle hand held dynamometer), It is planned to measure upper extremity muscle strength (grip strength) (with hand grip dynamometer), functional capacity (with 6 Minute Walk Test), postural stability, stability limits and sensory integration of balance (with Biodex Balance System®). In addition, individuals are expected to answer the questions of the International Physical Activity Questionnaire-Short Form (IPAQ) to evaluate their physical activity levels.

Type 2 diabetic patients

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who were followed up with the diagnosis of Diabetes Mellitus at the Internal Medicine Outpatient Clinic of the Eyup Additional Service Building of Bezmialem October Foundation University

You may qualify if:

  • Being diagnosed with Type 2 Diabetes Mellitus for at least 1 year
  • To be between the ages of 18-65
  • HbA1c value between 6.5-11
  • No cognitive/mental problems
  • Being able to walk independently
  • Being literate in Turkish

You may not qualify if:

  • Lack of co-operation
  • Patients with uncontrolled hypertension and uncontrolled arrhythmias
  • Vertigo and various vestibular system disorders
  • Those with severe neurological or severe respiratory diseases
  • Patients who have undergone percutaneous transluminal coronary angiography or have a cardiac pacemaker
  • Previous stroke, myocardial infarction
  • Patients with major musculoskeletal problems
  • Chronic renal failure
  • Chronic liver disease
  • Patients with hip or knee replacement surgery in the last 5 years
  • Patients with an injury involving the lower extremity in the last 6 months
  • Those who are pregnant
  • Those with haemolytic or renal anaemia
  • Those who cannot read and write Turkish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakıf Unıversty

Istanbul, 340060, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetic FootDiabetic NeuropathiesDiabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Reserach Assistant

Study Record Dates

First Submitted

May 24, 2023

First Posted

June 15, 2023

Study Start

June 6, 2023

Primary Completion

June 25, 2023

Study Completion

July 25, 2023

Last Updated

July 27, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations